Results 161 to 170 of about 119,037 (316)

A novel method using the level of mobility to predict mortality in patients admitted for decompensated cirrhosis: A prospective study

open access: yes, 2022
Liver Transplantation, EarlyView.
Andrew J. Groff   +5 more
wiley   +1 more source

Somatostatin Effect on Growth Factors in Hepatocellular Carcinoma. [PDF]

open access: yesCurr Issues Mol Biol
Tsakou A   +5 more
europepmc   +1 more source

Ascitic fluid concentrations of fibronectin and cholesterol [PDF]

open access: yes, 1990
Gerbes, Alexander L.   +3 more
core  

Liver Transplantation for Primary Biliary Cirrhosis [PDF]

open access: yes, 1989
Carcassonne, Christian   +4 more
core   +1 more source

Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Oncolytic viruses are a promising immunotherapeutic approach against many malignancies. However, it is unclear whether repeated doses have improved therapeutic value or may trigger greater side effects, especially in patients with hepatocellular carcinoma whose liver is chronically damaged.
Karen J. Scott   +10 more
wiley   +1 more source

Spatial multi‐omics identifies a NOTCH3‐mediated capillary–mCAF crosstalk driving immune exclusion in hepatocellular carcinoma

open access: yesiMeta, EarlyView.
Spatial multi‐omics defines a DLL4–NOTCH3–driven capillary–mCAF axis orchestrating fibrotic remodeling and immune exclusion in hepatocellular carcinoma tumor cores, conferring immune checkpoint blockade resistance. Targeting stromal NOTCH3 disrupts this pro‐fibrotic niche, enhances T cell infiltration, and synergizes with anti‐PD‐1 therapy ...
Fansen Ji   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy